Omega Healthcare Investors (OHI) EV to EBITDA (2009 - 2026)

Omega Healthcare Investors has disclosed EV to EBITDA across 16 years of filings, most recently posting 43.42 for Q2 2026.

• In Q2 2026, EV to EBITDA rose 19.6% year-over-year to 43.42; the TTM figure through Jun 2026 stood at 14.18 (up 9.46% YoY), while the FY2025 annual figure was 15.89, changed 0.34% from the prior year.
• EV to EBITDA came in at 43.42 for Q2 2026 at Omega Healthcare Investors, down from 63.36 in the prior quarter.
• In the past five years, EV to EBITDA ranged from a high of 68.26 in Q1 2023 to a low of 28.25 in Q1 2022.
• Average EV to EBITDA over 5 years is 53.51, with a median of 58.86 recorded in 2024.
• Year-over-year, EV to EBITDA plunged 31.11% in 2022 and surged 141.68% in 2023.
• Over 5 years, EV to EBITDA stood at 60.52 in 2022, then declined by 0.99% to 59.92 in 2023, then decreased by 1.71% to 58.89 in 2024, then rose by 1.52% to 59.79 in 2025, then declined by 27.38% to 43.42 in 2026.
• Per Business Quant data, the three most recent EV to EBITDA figures were 43.42 in Q2 2026, 63.36 in Q1 2026, and 59.79 in Q4 2025.